A prospective clinical case series reports that Gallium-68 FAPI PET-CT can visualize active myocardial fibrotic remodeling in Anderson–Fabry disease, using FAPI-46 to target fibroblast activation. In three patients with genetically confirmed disease, the molecular imaging results were integrated with cardiovascular MRI, echocardiography, and biomarker profiling, aiming to capture fibrosis activity rather than only established scar. The approach targets a practical diagnostic gap: late gadolinium enhancement highlights permanent fibrosis, while active remodeling may remain clinically relevant earlier in disease.